Design, Development and Evaluation of Buccal Tablets of Pregabalin

[...]buccal drug absorption can be promptly terminated in case of toxicity by removing the dosage form from the buccal cavity. Methods Drug- Excipient Compatibility study using FTIR Drug and excipients interaction was checked by comparing the FT-IR spectra of pure drug Pregabalin and FT-IR spectra o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research journal of pharmacy and technology 2017-02, Vol.10 (2), p.579-588
Hauptverfasser: Srikrishna, T., Anees, K. Mohammad, Priyanka, S. Lakshmi, Lavanya, K., Mounika, B., Krishna, M. Murali
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 588
container_issue 2
container_start_page 579
container_title Research journal of pharmacy and technology
container_volume 10
creator Srikrishna, T.
Anees, K. Mohammad
Priyanka, S. Lakshmi
Lavanya, K.
Mounika, B.
Krishna, M. Murali
description [...]buccal drug absorption can be promptly terminated in case of toxicity by removing the dosage form from the buccal cavity. Methods Drug- Excipient Compatibility study using FTIR Drug and excipients interaction was checked by comparing the FT-IR spectra of pure drug Pregabalin and FT-IR spectra of the physical mixture of drug and excipients. According to Noorana tehseen et al, F2,F5, F8, F11, F14, F17 formulations are prepared by using HPMCK4M 1.25, 3.75, 7.5, 11.25, 15 and18.75. the thickness of these formulations shows 2.51, 2.62, 2.46, 2.37, 2.42, 2.55 and the hardness is 3.6, 3.7, 3.5, 3.6, 3.7, 3.8. [...]Accelerated stability studies were carried out for 3 months, no significant change in the physical properties, drug content, and dissolution rate of formulation F6 was observed .As such formulation F6 developed is considered as an best formulations of Pregabalin. [...]the study fulfilled the objective of developing efficient buccal tablets of Pregabalin.
doi_str_mv 10.5958/0974-360X.2017.00115.9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1950387328</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1950387328</sourcerecordid><originalsourceid>FETCH-LOGICAL-c758-bde2ddb7f26037cb0e89874583d1039be28f7d3eebb247a42963e14be79ef7d3</originalsourceid><addsrcrecordid>eNo9kN1LwzAUxYMoOOb-BSn4ams-miZ5dF8qDBTcg28haW5HR5fOpB3439s62X25l3sO58APoXuCM664fMJK5Ckr8FdGMREZxoTwTF2hyUW4vtxE3qJZjHs8TCE5zeUEzZcQ651_TJZwgqY9HsB3ifEuWZ1M05uubn3SVsm8L0vTJFtjG-ji-PkIsDPWNLW_QzeVaSLM_vcUfa5X28Vrunl_eVs8b9JScJlaB9Q5KypaYCZKi0EqKXIumSOYKQtUVsIxAGtpLkxOVcGA5BaEglGYoodz6jG03z3ETu_bPvihUBPFMZOCUTm4irOrDG2MASp9DPXBhB9NsB6B6ZGFHrnoEZj-A6YV-wXbUl1o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1950387328</pqid></control><display><type>article</type><title>Design, Development and Evaluation of Buccal Tablets of Pregabalin</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Srikrishna, T. ; Anees, K. Mohammad ; Priyanka, S. Lakshmi ; Lavanya, K. ; Mounika, B. ; Krishna, M. Murali</creator><creatorcontrib>Srikrishna, T. ; Anees, K. Mohammad ; Priyanka, S. Lakshmi ; Lavanya, K. ; Mounika, B. ; Krishna, M. Murali</creatorcontrib><description>[...]buccal drug absorption can be promptly terminated in case of toxicity by removing the dosage form from the buccal cavity. Methods Drug- Excipient Compatibility study using FTIR Drug and excipients interaction was checked by comparing the FT-IR spectra of pure drug Pregabalin and FT-IR spectra of the physical mixture of drug and excipients. According to Noorana tehseen et al, F2,F5, F8, F11, F14, F17 formulations are prepared by using HPMCK4M 1.25, 3.75, 7.5, 11.25, 15 and18.75. the thickness of these formulations shows 2.51, 2.62, 2.46, 2.37, 2.42, 2.55 and the hardness is 3.6, 3.7, 3.5, 3.6, 3.7, 3.8. [...]Accelerated stability studies were carried out for 3 months, no significant change in the physical properties, drug content, and dissolution rate of formulation F6 was observed .As such formulation F6 developed is considered as an best formulations of Pregabalin. [...]the study fulfilled the objective of developing efficient buccal tablets of Pregabalin.</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.5958/0974-360X.2017.00115.9</identifier><language>eng</language><publisher>Raipur: A&amp;V Publications</publisher><subject>Bioavailability ; Drug delivery systems ; Drug dosages ; Metabolism ; Methods ; Pharmaceutical sciences ; Pharmacy ; Polymers</subject><ispartof>Research journal of pharmacy and technology, 2017-02, Vol.10 (2), p.579-588</ispartof><rights>Copyright A&amp;V Publications Feb 2017</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Srikrishna, T.</creatorcontrib><creatorcontrib>Anees, K. Mohammad</creatorcontrib><creatorcontrib>Priyanka, S. Lakshmi</creatorcontrib><creatorcontrib>Lavanya, K.</creatorcontrib><creatorcontrib>Mounika, B.</creatorcontrib><creatorcontrib>Krishna, M. Murali</creatorcontrib><title>Design, Development and Evaluation of Buccal Tablets of Pregabalin</title><title>Research journal of pharmacy and technology</title><description>[...]buccal drug absorption can be promptly terminated in case of toxicity by removing the dosage form from the buccal cavity. Methods Drug- Excipient Compatibility study using FTIR Drug and excipients interaction was checked by comparing the FT-IR spectra of pure drug Pregabalin and FT-IR spectra of the physical mixture of drug and excipients. According to Noorana tehseen et al, F2,F5, F8, F11, F14, F17 formulations are prepared by using HPMCK4M 1.25, 3.75, 7.5, 11.25, 15 and18.75. the thickness of these formulations shows 2.51, 2.62, 2.46, 2.37, 2.42, 2.55 and the hardness is 3.6, 3.7, 3.5, 3.6, 3.7, 3.8. [...]Accelerated stability studies were carried out for 3 months, no significant change in the physical properties, drug content, and dissolution rate of formulation F6 was observed .As such formulation F6 developed is considered as an best formulations of Pregabalin. [...]the study fulfilled the objective of developing efficient buccal tablets of Pregabalin.</description><subject>Bioavailability</subject><subject>Drug delivery systems</subject><subject>Drug dosages</subject><subject>Metabolism</subject><subject>Methods</subject><subject>Pharmaceutical sciences</subject><subject>Pharmacy</subject><subject>Polymers</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kN1LwzAUxYMoOOb-BSn4ams-miZ5dF8qDBTcg28haW5HR5fOpB3439s62X25l3sO58APoXuCM664fMJK5Ckr8FdGMREZxoTwTF2hyUW4vtxE3qJZjHs8TCE5zeUEzZcQ651_TJZwgqY9HsB3ifEuWZ1M05uubn3SVsm8L0vTJFtjG-ji-PkIsDPWNLW_QzeVaSLM_vcUfa5X28Vrunl_eVs8b9JScJlaB9Q5KypaYCZKi0EqKXIumSOYKQtUVsIxAGtpLkxOVcGA5BaEglGYoodz6jG03z3ETu_bPvihUBPFMZOCUTm4irOrDG2MASp9DPXBhB9NsB6B6ZGFHrnoEZj-A6YV-wXbUl1o</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Srikrishna, T.</creator><creator>Anees, K. Mohammad</creator><creator>Priyanka, S. Lakshmi</creator><creator>Lavanya, K.</creator><creator>Mounika, B.</creator><creator>Krishna, M. Murali</creator><general>A&amp;V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170201</creationdate><title>Design, Development and Evaluation of Buccal Tablets of Pregabalin</title><author>Srikrishna, T. ; Anees, K. Mohammad ; Priyanka, S. Lakshmi ; Lavanya, K. ; Mounika, B. ; Krishna, M. Murali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c758-bde2ddb7f26037cb0e89874583d1039be28f7d3eebb247a42963e14be79ef7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Bioavailability</topic><topic>Drug delivery systems</topic><topic>Drug dosages</topic><topic>Metabolism</topic><topic>Methods</topic><topic>Pharmaceutical sciences</topic><topic>Pharmacy</topic><topic>Polymers</topic><toplevel>online_resources</toplevel><creatorcontrib>Srikrishna, T.</creatorcontrib><creatorcontrib>Anees, K. Mohammad</creatorcontrib><creatorcontrib>Priyanka, S. Lakshmi</creatorcontrib><creatorcontrib>Lavanya, K.</creatorcontrib><creatorcontrib>Mounika, B.</creatorcontrib><creatorcontrib>Krishna, M. Murali</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science &amp; Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Srikrishna, T.</au><au>Anees, K. Mohammad</au><au>Priyanka, S. Lakshmi</au><au>Lavanya, K.</au><au>Mounika, B.</au><au>Krishna, M. Murali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design, Development and Evaluation of Buccal Tablets of Pregabalin</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2017-02-01</date><risdate>2017</risdate><volume>10</volume><issue>2</issue><spage>579</spage><epage>588</epage><pages>579-588</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>[...]buccal drug absorption can be promptly terminated in case of toxicity by removing the dosage form from the buccal cavity. Methods Drug- Excipient Compatibility study using FTIR Drug and excipients interaction was checked by comparing the FT-IR spectra of pure drug Pregabalin and FT-IR spectra of the physical mixture of drug and excipients. According to Noorana tehseen et al, F2,F5, F8, F11, F14, F17 formulations are prepared by using HPMCK4M 1.25, 3.75, 7.5, 11.25, 15 and18.75. the thickness of these formulations shows 2.51, 2.62, 2.46, 2.37, 2.42, 2.55 and the hardness is 3.6, 3.7, 3.5, 3.6, 3.7, 3.8. [...]Accelerated stability studies were carried out for 3 months, no significant change in the physical properties, drug content, and dissolution rate of formulation F6 was observed .As such formulation F6 developed is considered as an best formulations of Pregabalin. [...]the study fulfilled the objective of developing efficient buccal tablets of Pregabalin.</abstract><cop>Raipur</cop><pub>A&amp;V Publications</pub><doi>10.5958/0974-360X.2017.00115.9</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0974-3618
ispartof Research journal of pharmacy and technology, 2017-02, Vol.10 (2), p.579-588
issn 0974-3618
0974-360X
0974-306X
language eng
recordid cdi_proquest_journals_1950387328
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Bioavailability
Drug delivery systems
Drug dosages
Metabolism
Methods
Pharmaceutical sciences
Pharmacy
Polymers
title Design, Development and Evaluation of Buccal Tablets of Pregabalin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T12%3A33%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design,%20Development%20and%20Evaluation%20of%20Buccal%20Tablets%20of%20Pregabalin&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Srikrishna,%20T.&rft.date=2017-02-01&rft.volume=10&rft.issue=2&rft.spage=579&rft.epage=588&rft.pages=579-588&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.5958/0974-360X.2017.00115.9&rft_dat=%3Cproquest_cross%3E1950387328%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1950387328&rft_id=info:pmid/&rfr_iscdi=true